Elos Medtech applies for de-listing from Nasdaq Stockholm
The board of directors of Elos Medtech has today resolved to apply for de-listing of the Company’s shares from Nasdaq Stockholm as a result of TA Associates, through EM Intressenter AB (“EM Intressenter”), controlling more than 90 percent of the shares in Elos Medtech AB (publ) (“Elos Medtech” or the “Company”), today having initiated compulsory redemption of the remaining shares in the Company. EM Intressenter has informed the board of directors of Elos Medtech that EM Intressenter initiates compulsory redemption of the remaining shares in Elos Medtech and requested that the shares in